1004316-91-9 Usage
Uses
Used in Pharmaceutical Industry:
Moxifloxacin is used as an antibacterial agent for treating various bacterial infections, including sinusitis, pneumonia, and skin infections. Its application is based on its effectiveness in inhibiting essential bacterial enzymes, thereby preventing the growth and spread of bacteria.
Used in Oral and Intravenous Formulations:
Moxifloxacin is available in both oral and intravenous formulations, allowing for flexible treatment options depending on the severity and nature of the infection. Its use in these formulations is due to its well-tolerated nature and the convenience it offers for patients and healthcare providers.
While the provided materials do not explicitly list different applications in various industries, the primary use of Moxifloxacin is in the pharmaceutical industry for medical treatment. However, it is important to note that the potential side effects, such as nausea, dizziness, and diarrhea, should be considered when prescribing and administering this medication.
Check Digit Verification of cas no
The CAS Registry Mumber 1004316-91-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,3,1 and 6 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1004316-91:
(9*1)+(8*0)+(7*0)+(6*4)+(5*3)+(4*1)+(3*6)+(2*9)+(1*1)=89
89 % 10 = 9
So 1004316-91-9 is a valid CAS Registry Number.
1004316-91-9Relevant academic research and scientific papers
METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS
-
, (2013/08/15)
Methods and intermediates useful for preparing a compound of formula I and salts thereof.
MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS
-
Page/Page column 217-218, (2008/06/13)
The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.
